[Adjuvant chemotherapy in non-small-cell lung cancer: proven survival benefit].
Serke
M
M
Pneumologie II, Lungenklinik Heckeshorn, Zentralklinik Emil-von-Behring, Berlin. m.serke@zevb.de
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis; D013997:Time Factors